Venetoclax alone or in combination with rituximab for Japanese patients with relapsed/ refractory chronic lymphocytic leukemia

Category Primary study
JournalHemaSphere
Year 2019
This article has no abstract
Epistemonikos ID: d9e9ae6edef850e1f323b2f1efdfe18f367b1bfb
First added on: Feb 11, 2025